JP2014524475A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524475A5
JP2014524475A5 JP2014527282A JP2014527282A JP2014524475A5 JP 2014524475 A5 JP2014524475 A5 JP 2014524475A5 JP 2014527282 A JP2014527282 A JP 2014527282A JP 2014527282 A JP2014527282 A JP 2014527282A JP 2014524475 A5 JP2014524475 A5 JP 2014524475A5
Authority
JP
Japan
Prior art keywords
amino
pyridazin
phenyl
oxo
dihydropyrimido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014527282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524475A (ja
JP5993010B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/051980 external-priority patent/WO2013028818A1/en
Publication of JP2014524475A publication Critical patent/JP2014524475A/ja
Publication of JP2014524475A5 publication Critical patent/JP2014524475A5/ja
Application granted granted Critical
Publication of JP5993010B2 publication Critical patent/JP5993010B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014527282A 2011-08-23 2012-08-23 ピリミド−ピリダジノン化合物及びその使用 Active JP5993010B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161526525P 2011-08-23 2011-08-23
US61/526,525 2011-08-23
PCT/US2012/051980 WO2013028818A1 (en) 2011-08-23 2012-08-23 Pyrimido- pyridazinone compounds and use thereof

Publications (3)

Publication Number Publication Date
JP2014524475A JP2014524475A (ja) 2014-09-22
JP2014524475A5 true JP2014524475A5 (enExample) 2015-10-15
JP5993010B2 JP5993010B2 (ja) 2016-09-14

Family

ID=46829884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014527282A Active JP5993010B2 (ja) 2011-08-23 2012-08-23 ピリミド−ピリダジノン化合物及びその使用

Country Status (14)

Country Link
US (5) US8729079B2 (enExample)
EP (4) EP3392252B1 (enExample)
JP (1) JP5993010B2 (enExample)
CN (2) CN108707151B (enExample)
BR (1) BR112014003981A2 (enExample)
CA (1) CA2846187A1 (enExample)
DK (2) DK2748166T3 (enExample)
ES (2) ES2969977T3 (enExample)
FI (1) FI3392252T3 (enExample)
HU (1) HUE065564T2 (enExample)
IL (1) IL231082A (enExample)
MX (1) MX361458B (enExample)
PL (1) PL2748166T3 (enExample)
WO (1) WO2013028818A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014003981A2 (pt) * 2011-08-23 2017-03-07 Endo Pharmaceuticals Inc compostos de pirimido-piridazinona e seu uso
AR106830A1 (es) * 2015-12-04 2018-02-21 Asana Biosciences Llc Usos de piridazinonas para tratar el cáncer
WO2018187294A1 (en) * 2017-04-03 2018-10-11 Asana Biosciences, Llc Pyrimido-pyridazinone compound combinations, methods, kits and formulations thereof
CN110809471A (zh) 2017-04-28 2020-02-18 阿沙纳生物科学公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型
CN111961035B (zh) * 2019-05-20 2022-11-01 南京科技职业学院 一类含有羟基异喹啉类结构的化合物、药物组合物以及其应用
CN114174298B (zh) * 2019-08-14 2023-08-01 正大天晴药业集团南京顺欣制药有限公司 哒嗪酮并嘧啶类衍生物及其医药用途
CN113583026B (zh) * 2020-04-30 2024-06-14 杭州英创医药科技有限公司 一类含有稠合三环结构的化合物
CN115916747A (zh) * 2020-07-01 2023-04-04 四川海思科制药有限公司 一种并环杂环衍生物及其在医药上的应用
AU2022421224A1 (en) * 2021-12-22 2024-06-20 The Regents Of The University Of California Covalently binding inhibitors of g12s, g12d and/or g12e mutants of k-ras gtpase
US20250171448A1 (en) 2022-02-23 2025-05-29 Teva Pharmaceuticals International Gmbh Solid state forms of gusacitinib
WO2023192989A2 (en) * 2022-04-01 2023-10-05 Azkarra Therapeutics, Inc. Phthalazinone compounds as parp7 inhibitors
WO2025020171A1 (en) * 2023-07-27 2025-01-30 Libertas Bio, Inc. Crystalline forms of a jak/syk inhibitor
IL326153A (en) 2023-07-27 2026-03-01 Libertas Bio Inc Solid state forms of GUSACITINIB

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756508A (fr) 1969-09-24 1971-03-01 Takeda Chemical Industries Ltd Derives de pyrimidopyridazine
CA1004223A (en) * 1972-05-12 1977-01-25 Theodor Denzel Amino derivatives of pyrido(2,3-d)pyridazine carboxylic acids and esters
JPS4948695U (enExample) 1972-07-29 1974-04-27
JPS50101387A (enExample) * 1974-01-16 1975-08-11
CA1052046A (en) 1974-01-21 1979-04-03 American Cyanamid Company Unsymmetrically substituted 1,4-dioxane-2,5-diones
US5369086A (en) 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
JPH0948695A (ja) 1995-08-02 1997-02-18 Toshiba Ceramics Co Ltd シリコン単結晶の製造方法
JP2002504550A (ja) 1998-02-25 2002-02-12 ファルマシア・アンド・アップジョン・カンパニー 抗微生物剤として有用な置換アミノメチルイソオキサゾリン誘導体
ID28376A (id) 1998-11-10 2001-05-17 Janssen Pharmaceutica Nv Pirimidina yang menghambat replikasi hiv
JP4977940B2 (ja) * 2000-09-22 2012-07-18 エム・エス・ディー・オス・ベー・フェー 二環式ヘテロ芳香族化合物
CA2446514A1 (en) 2001-04-30 2002-11-07 Glaxo Group Limited Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
WO2003075828A2 (en) 2002-03-11 2003-09-18 Zetiq Technologies Ltd. Compounds useful in the treatment of cancer
IL166241A0 (en) 2002-07-29 2006-01-15 Rigel Pharmaceuticals Inc Method of treating or preventing autoimmune diseases with 2,4-pyrimidinedinediamine compounds
US20040242568A1 (en) 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
ES2421139T3 (es) 2003-07-30 2013-08-29 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
TW200538120A (en) 2004-02-20 2005-12-01 Kirin Brewery Compound having TGF-beta inhibitory activity and pharmaceutical composition containing same
US8575342B2 (en) 2004-09-30 2013-11-05 Tibotech Pharmaceuticals Ltd. HIV inhibiting 5-heterocyclyl pyrimidines
NZ555334A (en) 2004-12-24 2010-05-28 Spinifex Pharm Pty Ltd Method of treatment or prophylaxis of a neuropathic condition using AT2 receptor antagonist
CN101189234B (zh) 2005-03-25 2011-08-17 泰博特克药品有限公司 Hcv的杂二环抑制剂
BRPI0609650A2 (pt) 2005-03-25 2010-04-20 Tibotec Pharm Ltd inibidores heterobicìlicos de hvc
EP1874304B1 (en) 2005-04-29 2009-07-15 Janssen Pharmaceutica N.V. Benzotriazole derivatives as cannabinoid receptor antagonists
WO2007063934A1 (ja) * 2005-12-02 2007-06-07 Mitsubishi Tanabe Pharma Corporation 脂環式複素環化合物
WO2007082131A1 (en) 2006-01-09 2007-07-19 Bristol-Myers Squibb Company Process for the preparation of hydroxy substituted heterocycles
WO2007125405A2 (en) 2006-05-01 2007-11-08 Pfizer Products Inc. Substituted 2-amino-fused heterocyclic compounds
GB0625196D0 (en) 2006-12-18 2007-01-24 7Tm Pharma As Modulators of cannabinoid receptor
MX347085B (es) * 2006-12-28 2017-04-06 Abbott Laboratories * Inhibidores de la poli (adp-ribosa) polimerasa.
BRPI0808772A2 (pt) 2007-03-14 2014-08-12 Exelixis Inc Inibidores da via de hedgehog
TW200942537A (en) * 2008-02-01 2009-10-16 Irm Llc Compounds and compositions as kinase inhibitors
JP2012504157A (ja) * 2008-09-30 2012-02-16 アストラゼネカ アクチボラグ 複素環式jakキナーゼ阻害剤
TW201016676A (en) 2008-10-03 2010-05-01 Astrazeneca Ab Heterocyclic derivatives and methods of use thereof
EA022417B1 (ru) 2008-10-21 2015-12-30 Саймабэй Терапевтикс, Инк. Арильные агонисты рецептора gpr120 и их применение
JP5993742B2 (ja) * 2009-10-29 2016-09-14 ジェノスコ キナーゼ阻害剤
TW201130852A (en) * 2009-12-23 2011-09-16 Abbott Lab Novel thienopyrrole compounds
US8440662B2 (en) 2010-10-31 2013-05-14 Endo Pharmaceuticals, Inc. Substituted quinazoline and pyrido-pyrimidine derivatives
BR112014003981A2 (pt) * 2011-08-23 2017-03-07 Endo Pharmaceuticals Inc compostos de pirimido-piridazinona e seu uso
US9145411B2 (en) 2012-08-02 2015-09-29 Asana Biosciences, Llc Substituted amino-pyrimidine derivatives
AR106830A1 (es) * 2015-12-04 2018-02-21 Asana Biosciences Llc Usos de piridazinonas para tratar el cáncer
CN110809471A (zh) * 2017-04-28 2020-02-18 阿沙纳生物科学公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型

Similar Documents

Publication Publication Date Title
JP2022531801A5 (enExample)
ES2922174T3 (es) Compuestos de indol sustituidos con amida útiles como inhibidores de TLR
JP2019517596A5 (enExample)
KR20230024251A (ko) 신규 plk1 분해 유도 화합물
KR20240050360A (ko) Shp2 단백질 분해활성을 갖는 화합물 및 이들의 의약 용도
AU2016352813B2 (en) Novel pyrazolo pyrimidine derivatives
AU2013210438B2 (en) Pyrazine carboxamide compound
JP2023501253A5 (enExample)
RU2018124289A (ru) Применения пиримидо-пиридазинонов для лечения рака
ES2946274T3 (es) Inhibidores de TRPC6
JP7366994B2 (ja) 自己免疫疾患治療用の新規ピペラジン化合物
AU2015304883A1 (en) Aminopyrimidinyl compounds as JAK inhibitors
KR102646850B1 (ko) 안드로겐 수용체 분해용 화합물 및 이들의 의약 용도
RU2013102881A (ru) Новые конденсированные пиримидиновые производные для ингибирования тирозинкиназной активности
RU2014154397A (ru) Соединения тетрагидропиразолопиримидина
WO2014085210A1 (en) Inhibitors of the renal outer medullary potassium channel
KR20140138851A (ko) 류코트리엔 생성 억제를 위해 기타 활성제와 병용된 벤조디옥산
KR20150127721A (ko) 디하이드로피리다진-3,5-디온 유도체
WO2024059808A1 (en) Wee1 inhibitors and methods for treating cancer
JP2024009891A (ja) T型カルシウムチャネル阻害剤
RU2666894C2 (ru) Производные пиперидинмочевины
AU2023330130A1 (en) Compounds and methods for modulating her2
KR20230159524A (ko) Bcl-2 저해제로서 ((3-나이트로페닐)설포닐)아세트아마이드를 갖는 화합물
KR20230104781A (ko) Bcr-abl 티로신 키나아제의 억제를 위한 5- 및 6-아자인돌 화합물
RU2006146621A (ru) Производные нафталина, пригодные в качестве лигандов рецепторов 3 гистамина